149 related articles for article (PubMed ID: 32692618)
21. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
22. The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics.
Rein DB; Borton J; Liffmann DK; Wittenborn JS
Hepatology; 2016 Apr; 63(4):1135-44. PubMed ID: 26707033
[TBL] [Abstract][Full Text] [Related]
23. Impact of Travel Time on Health Care Costs and Resource Use by Phase of Care for Older Patients With Cancer.
Rocque GB; Williams CP; Miller HD; Azuero A; Wheeler SB; Pisu M; Hull O; Rocconi RP; Kenzik KM
J Clin Oncol; 2019 Aug; 37(22):1935-1945. PubMed ID: 31184952
[TBL] [Abstract][Full Text] [Related]
24. Incremental Health Care Costs of Anxiety and Depression Among Medicare Beneficiaries With Cancer.
Birch K; Chung S; Zion SR; MacEwan JP; Malecki MJ
JCO Oncol Pract; 2023 May; 19(5):e660-e671. PubMed ID: 36800552
[TBL] [Abstract][Full Text] [Related]
25. Older women with localized breast cancer: costs and survival rates increased across two time periods.
Feinstein AJ; Long J; Soulos PR; Ma X; Herrin J; Frick KD; Chagpar AB; Krumholz HM; Yu JB; Ross JS; Gross CP
Health Aff (Millwood); 2015 Apr; 34(4):592-600. PubMed ID: 25847641
[TBL] [Abstract][Full Text] [Related]
26. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011.
Dinan MA; Wilson LE; Reed SD
J Natl Compr Canc Netw; 2019 Mar; 17(3):245-254. PubMed ID: 30865923
[TBL] [Abstract][Full Text] [Related]
28. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
[TBL] [Abstract][Full Text] [Related]
29. Influence of primary care on breast cancer outcomes among Medicare beneficiaries.
Roetzheim RG; Ferrante JM; Lee JH; Chen R; Love-Jackson KM; Gonzalez EC; Fisher KJ; McCarthy EP
Ann Fam Med; 2012; 10(5):401-11. PubMed ID: 22966103
[TBL] [Abstract][Full Text] [Related]
30. Economic burden of renal cell carcinoma among older adults in the targeted therapy era.
Kale HP; Mays DP; Nadpara PA; Slattum PW; Paul AK; Carroll NV
Urol Oncol; 2019 Jun; 37(6):356.e19-356.e28. PubMed ID: 30846388
[TBL] [Abstract][Full Text] [Related]
31. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
34. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
35. The cost of glaucoma care provided to Medicare beneficiaries from 2002 to 2009.
Quigley HA; Cassard SD; Gower EW; Ramulu PY; Jampel HD; Friedman DS
Ophthalmology; 2013 Nov; 120(11):2249-57. PubMed ID: 23769330
[TBL] [Abstract][Full Text] [Related]
36. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
37. Differences in Medicare Expenditures Between Appalachian and Nationally Representative Cohorts of Elderly Women With Breast Cancer: An Application of Decomposition Technique.
Vyas A; Madhavan SS; Sambamoorthi U
J Natl Compr Canc Netw; 2017 May; 15(5):578-587. PubMed ID: 28476737
[No Abstract] [Full Text] [Related]
38. The Cost to Medicare of Bladder Cancer Care.
Sloan FA; Yashkin AP; Akushevich I; Inman BA
Eur Urol Oncol; 2020 Aug; 3(4):515-522. PubMed ID: 31412015
[TBL] [Abstract][Full Text] [Related]
39. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
40. Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes.
Zeidan AM; Wang R; Davidoff AJ; Ma S; Zhao Y; Gore SD; Gross CP; Ma X
Cancer; 2016 May; 122(10):1598-607. PubMed ID: 26970288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
